Literature DB >> 30871795

Acute Vasoreactivity Testing during Cardiac Catheterization of Neonates with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension.

Benjamin S Frank1, Michal Schäfer2, Alicia Grenolds3, D Dunbar Ivy2, Steven H Abman3, Jeffrey R Darst2.   

Abstract

OBJECTIVES: To assess whether better baseline pulmonary hemodynamics or positive acute vasoreactivity testing (AVT) during cardiac catheterization are associated with improved outcomes in infants with bronchopulmonary dysplasia (BPD) and pulmonary hypertension (PH). STUDY
DESIGN: This retrospective, single-center study included 26 premature neonates with BPD who underwent catheterization to evaluate PH. AVT was assessed with exposure to 100% fractional inspired oxygen with or without inhaled nitric oxide. AVT was positive if the patient met the Barst criteria or increased shunt volume and decreased pulmonary vascular resistance index by >50%.
RESULTS: At baseline, the median pulmonary artery mean pressure was 29 mm Hg (IQR, 24-35) and the pulmonary vascular resistance index was 5.3 units*m2 (IQR, 3.5-6.9). Nine patients (35%) had a positive AVT response, which was associated with a decreased risk of death or tracheostomy by 2-year follow-up (hazard ratio, 0.15; P = .02). Baseline pulmonary hemodynamics and the presence of left ventricular diastolic dysfunction were not associated with late outcomes in this cohort.
CONCLUSIONS: We found that 35% of infants with BPD who underwent catheterization had positive AVT and that a positive response was associated with better long-term outcomes than nonresponders. AVT better distinguishes higher from lower risk PH in infants with BPD than baseline pulmonary hemodynamics. AVT may aid in the assessment of disease severity and management of BPD-associated PH.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  acute vasoreactivity testing; bronchopulmonary dysplasia; cardiac catheterization; echocardiography; neonatal; prematurity; pulmonary hypertension

Year:  2019        PMID: 30871795     DOI: 10.1016/j.jpeds.2018.12.004

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  10 in total

Review 1.  Prematurity and Pulmonary Vein Stenosis: The Role of Parenchymal Lung Disease and Pulmonary Vascular Disease.

Authors:  Shilpa Vyas-Read; Nidhy P Varghese; Divya Suthar; Carl Backes; Satyan Lakshminrusimha; Christopher J Petit; Philip T Levy
Journal:  Children (Basel)       Date:  2022-05-12

Review 2.  Inhaled nitric oxide use in neonates: Balancing what is evidence-based and what is physiologically sound.

Authors:  Laurie G Sherlock; Clyde J Wright; John P Kinsella; Cassidy Delaney
Journal:  Nitric Oxide       Date:  2019-12-19       Impact factor: 4.427

Review 3.  Early diagnosis and targeted approaches to pulmonary vascular disease in bronchopulmonary dysplasia.

Authors:  Catheline Hocq; Laetitia Vanhoutte; Axelle Guilloteau; Anna Claudia Massolo; Bénédicte Van Grambezen; Kate Carkeek; Fiammetta Piersigilli; Olivier Danhaive
Journal:  Pediatr Res       Date:  2021-03-05       Impact factor: 3.756

4.  Cardiac Catheterization and Hemodynamics in a Multicenter Cohort of Children with Pulmonary Hypertension.

Authors:  Erika B Rosenzweig; Angela Bates; Mary P Mullen; Steven H Abman; Eric D Austin; Allen Everett; Jeffrey Fineman; Jeffery Feinstein; Rachel K Hopper; John P Kinsella; Usha S Krishnan; Minmin Lu; Kenneth D Mandl; J Usha Raj; Nidhy Varghese; Delphine Yung; Stephanie S Handler; Lynn A Sleeper
Journal:  Ann Am Thorac Soc       Date:  2022-06

Review 5.  Oxygen therapy in preterm infants with pulmonary hypertension.

Authors:  Praveen Chandrasekharan; Satyan Lakshminrusimha
Journal:  Semin Fetal Neonatal Med       Date:  2019-12-03       Impact factor: 3.726

6.  Pediatric Pulmonary Hypertension: Definitions, Mechanisms, Diagnosis, and Treatment.

Authors:  Devashis Mukherjee; Girija G Konduri
Journal:  Compr Physiol       Date:  2021-06-30       Impact factor: 8.915

7.  Assessing pulmonary circulation in severe bronchopulmonary dysplasia using functional echocardiography.

Authors:  Arvind Sehgal; Douglas Blank; Calum T Roberts; Samuel Menahem; Stuart B Hooper
Journal:  Physiol Rep       Date:  2021-01

Review 8.  Role of functional echocardiographic parameters in the diagnosis of bronchopulmonary dysplasia-associated pulmonary hypertension.

Authors:  Soham Dasgupta; Joan C Richardson; Ashraf M Aly; Sunil K Jain
Journal:  J Perinatol       Date:  2021-03-08       Impact factor: 3.225

9.  Prenatal Maternal Lipopolysaccharide and Mild Newborn Hyperoxia Increase Intrapulmonary Airway but Not Vessel Reactivity in a Mouse Model.

Authors:  Margaret E Kuper-Sassé; Peter M MacFarlane; Catherine A Mayer; Richard J Martin; Y S Prakash; Christina M Pabelick; Thomas M Raffay
Journal:  Children (Basel)       Date:  2021-03-05

Review 10.  Pulmonary hypertension in bronchopulmonary dysplasia.

Authors:  Georg Hansmann; Hannes Sallmon; Charles C Roehr; Stella Kourembanas; Eric D Austin; Martin Koestenberger
Journal:  Pediatr Res       Date:  2020-06-10       Impact factor: 3.756

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.